Health
Anti-SARS-CoV-2 hyperimmune globulin produced from convalescent plasma pool has 3-fold antibody neutralizing activity – News-Medical.Net
In a recent study published in the preprint server bioRxiv, researchers from the Grifols Bioscience Research Group reported on the collection of convalescent plasma…
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus emerged from Wuhan, China, in late 2019 and rapidly spread across the world, progressing into a full-blown pandemic. Since it is a novel virus, scientists worldwide immediately started working on developing a vaccine or effective therapeutic agents to fight SARS-CoV-2.
The use of convalescent plasma in the treatment of infectious diseases
Convalescent plasma has now been identified as a potential treatment option for coronavirus…
-
Business14 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business10 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General20 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News10 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred